Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep-Oct;6(5):326-9.
doi: 10.4103/2229-5178.164480.

Narrowband UVB phototherapy in pityriasis rosea

Vijayeeta Jairath  1 , Madan Mohan  1 , Nidhi Jindal  2 , Paritosh Gogna  1 , Clarify Syrty  1 , Priyadarshini Mookalamada Monnappa  1 , Sarabjit Kaur  2 , Manu Sehrawat  2
Affiliations

Narrowband UVB phototherapy in pityriasis rosea

Vijayeeta Jairath et al. Indian Dermatol Online J. 2015 Sep-Oct.

Abstract

Objective: Pityriasis rosea (PR) is an acute self-limiting disease. Despite vigorous efforts by generations of researchers since nearly 150 years, present treatment modalities for PR are not very gratifying. Ultraviolet radiation has been recommended in PR, although only a few studies validate this proposal. This study was conducted to explore the therapeutic effect of NBUVB on the symptoms, course, and severity of PR.

Materials and methods: This study involved a hundred patients who were randomly divided into two groups, using computer-generated randomization chart. Group A underwent treatment with fixed dose NBUVB of 250 mJ/cm(2) three times (nonconsecutive) a week for 4 weeks. Group B formed the placebo group who did not receive any treatment. The two groups were compared with each other for the intensity of pruritis, course and duration of disease, and PR severity score (PRSS).

Results: The t values of improvement in PRSS score in Group A (t = 12.796) were higher as compared with that in Group B (t = 10.066). Similarly, the t value of the pruritus scale in Group A (t = 7.758) was higher than Group B (t = 5.754) indicating the symptomatic improvement in itching.

Conclusion: Fixed-dose NBUVB phototherapy resulted in marked improvement in the severity and symptoms of the disease as quantitatively assessed by PRSS.

Keywords: Narrowband ultraviolet B phototherapy; PR severity score; pityriasis rosea.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
A 23-year-old male patient with papulosquamous PR showing marked improvement in the severity of disease after NBUVB radiation
Figure 2
Figure 2
A 17-year-old male patient with erythematous scaly eruption of PR before NBUVB and healing of lesions with hyperpigmentation after treatment
See this image and copyright information in PMC

References

    1. Bjornberg A, Tegner E. Pityriasis rosea. In: Fitzpatrick TB, Eisen AZ, editors. Fitzpatrick's Dermatology in General Medicine. 5th ed. New York: McGraw Hill Book Co; pp. 445–9.
    1. Rajpara SN, Ormerod AD, Gallaway L. Adalimumab-induced pityriasis rosea. J Eur Acad Dermatol Venereol. 2007;21:1294–6. - PubMed
    1. Chuh A, Lee A, Zawar V, Sciallis G, Kempf W. Pityriasis rosea—An update. Indian J Dermatol Venereol Leprol. 2005;71:311–5. - PubMed
    1. Leenutaphong V, Jiamton S. UVB phototherapy for pityriasis rosea: A bilateral comparison study. J Am Acad Dermatol. 1995;33:996–9. - PubMed
    1. Merchant M, Hammond R. Controlled study of ultraviolet light for Pityriasis rosea. Cutis. 1974;14:548–9.